FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Central Admixture Pharmacy Services rocuronium 50 mg/5 mL Recall

rocuronium 50 mg/5 mL (10 mg/mL), 5 mL Syringes, Rx only, this drug was repackaged by C…

Central Admixture Pharmacy Services, Inc. · Phoenix, AZ

Risk level
Class II
Reported by FDA
Sep 6, 2023
Recall ID
D-1113-2023
Check your lot numberHow we source this data

Summary

Central Admixture Pharmacy Services recalled rocuronium 50 mg/5 mL starting Aug 17, 2023. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-1113-2023 on Sep 6, 2023. Reason: Lack of Assurance of Sterility:Lack of validation data for sanitization cycles. Status: Terminated.

Why it was recalled

Lack of Assurance of Sterility:Lack of validation data for sanitization cycles

Product description

rocuronium 50 mg/5 mL (10 mg/mL), 5 mL Syringes, Rx only, this drug was repackaged by CAPS Inc, 2200 South 43rd Avenue, Pheonix, AZ, NDC 72196-6010-1.

Lot numbers, UPCs & expiration codes

Lot# 36-262729, 36-262982, 36-262981, 36-262732, 36-262731, 36-262730, Exp 10/11/2023 ;

Where it was sold

Nationwide in the USA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1113-2023
Classification
Class II
Status
Terminated
Recall initiated
Aug 17, 2023
FDA report date
Sep 6, 2023
Quantity
3519 Syringes
Recall type
Voluntary: Firm initiated
Recalling firm
Central Admixture Pharmacy Services, Inc.

Original FDA data

Every field from FDA enforcement report D-1113-2023, exactly as published.

Show all FDA fields
City
Phoenix
State
AZ
Status
Terminated
Country
United States
Event ID
92898
Address
2200 S 43rd Ave
Code information
Lot# 36-262729, 36-262982, 36-262981, 36-262732, 36-262731, 36-262730, Exp 10/11/2023 ;
Postal code
85043-3909
Report date
Sep 6, 2023
Product type
Drugs
Recall number
D-1113-2023
Classification
Class II
Recalling firm
Central Admixture Pharmacy Services, Inc.
Product quantity
3519 Syringes
Termination date
Mar 27, 2025
Reason for recall
Lack of Assurance of Sterility:Lack of validation data for sanitization cycles
Voluntary / mandated
Voluntary: Firm initiated
Product description
rocuronium 50 mg/5 mL (10 mg/mL), 5 mL Syringes, Rx only, this drug was repackaged by CAPS Inc, 2200 South 43rd Avenue, Pheonix, AZ, NDC 72196-6010-1.
Distribution pattern
Nationwide in the USA
Recall initiation date
Aug 17, 2023
Initial firm notification
Letter
Center classification date
Aug 28, 2023

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1113-2023, published Sep 6, 2023. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls